Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

TIG:BB

0.7570 EUR 0.0010 0.13%

As of 04:13:41 ET on 03/06/2015.

Company Profile for TiGenix NV (TIG)

TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.

Contact Information

TiGenix NV

Romeinse straat 12 bus 2
Leuven, 3001
Belgium
Phone: 32-1-639-60-60
Fax: 32-1-639-60-70

Key Executives for TiGenix NV (TIG)

Eduardo Bravo Fernandez De AraozCEO/Managing DirectorClaudia D AugustaCFO/Secy/Compliance Officer
Wilfried DalemansChief Technology OfficerMarie Paule RichardChief Medical Officer
Hans HerklotsDir:Investor & Media Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil